Expression Pattern of the Plasminogen Activator-plasmin System in Human Cholesteatoma
Overview
Authors
Affiliations
The plasminogen activator-plasmin system plays a pivotal role in the delicately regulated process of extracellular matrix remodeling. Recent studies have shown that an imbalance of proteolytic enzymes over specific inhibitors in this system may lead to an aggressive, expanding, and infiltrating cellular phenotype. As cholesteatoma resembles a tumor in many ways, we investigated the pattern of expression for members of the plasminogen activator-plasmin system in 12 human cholesteatomas, using immunohistochemistry. As controls, 3 tympanic membranes and 4 ear canal skin specimens were used. In contrast to the tympanic membranes, all cholesteatoma specimens showed a strong expression of plasminogen at the basal epithelial cell layers. In ear canal skin, only the basal surface of the most basal epithelia stained discretely positive. The urokinase-type plasminogen activator (uPA) could be detected in the basal stratum of the cholesteatoma matrix and in the surrounding granulation tissue, while tissue-type plasminogen activator (tPA) was not detectable at all. Plasminogen activator inhibitor-1 (PAI-1) was expressed in both the granulation tissue and the granular cell layer of the matrix, but not in the basal epithelial cells; PAI-2 showed a pericellular expression pattern in the subbasal and granular cell layers. Neither uPA, tPA, nor the PAIs could be detected in tympanic membrane controls; ear canal skin showed the same staining pattern as cholesteatoma only for PAI-2. Our data demonstrate that there is a clear imbalance in favor of proteolytic activity in the basal epithelial layers of the cholesteatoma matrix, which might at least partly account for the aggressive behavior of this tumorlike lesion. Further, the pattern of expression resembles the pattern described for several epithelial malignancies.
Transcription and microRNA Profiling of Cultured Human Tympanic Membrane Epidermal Keratinocytes.
Aabel P, Utheim T, Olstad O, Rask-Andersen H, Dilley R, von Unge M J Assoc Res Otolaryngol. 2018; 19(3):243-260.
PMID: 29623476 PMC: 5962475. DOI: 10.1007/s10162-018-0660-1.
The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.
Xie S, Wang X, Ren J, Liu W Eur Arch Otorhinolaryngol. 2016; 274(5):2071-2078.
PMID: 27981350 DOI: 10.1007/s00405-016-4422-6.
The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.
Juhn S, Jung M, Hoffman M, Drew B, Preciado D, Sausen N Clin Exp Otorhinolaryngol. 2009; 1(3):117-38.
PMID: 19434244 PMC: 2671742. DOI: 10.3342/ceo.2008.1.3.117.